Overview
Portal systemic encephalopathy refers to neuropsychiatric symptoms resulting from abnormal portosystemic shunting, bypassing the liver's detoxification function, often observed in non-cirrhotic patients 2.Diagnosis
Suspect hepatic encephalopathy in non-cirrhotic patients presenting with psychoneurological symptoms and hyperammonemia 2.
Abnormal angiograms of the portal vein, superior mesenteric vein, or splenic vein indicate portal-systemic shunting 2.
Misdiagnosis as psychiatric conditions (dementia, depression) is common; accurate imaging crucial 2.Management
First-line treatments: Lactulose to reduce ammonia absorption, rifaximin for gut decontamination 2.
Adjunctive therapies: Dietary protein restriction, branched-chain amino acid supplementation 2.
Specific interventions: Percutaneous transcatheter embolization for identified shunts (e.g., inferior mesenteric-caval shunt) 1.Special Populations
Pediatrics: Susceptible to misdiagnosis; accurate imaging essential for diagnosis 2.
Elderly: Increased risk of misdiagnosis as psychiatric disorders; thorough diagnostic workup recommended 2.Key Recommendations
Accurately diagnose portal systemic encephalopathy through imaging techniques like angiography to identify portosystemic shunts 2 (Evidence: Strong).
Initiate treatment with lactulose and consider rifaximin for non-cirrhotic patients presenting with encephalopathy 2 (Evidence: Moderate).
Perform transcatheter embolization for definitive treatment of identifiable shunts to prevent recurrence 1 (Evidence: Weak).References
1 Otake M, Kobayashi Y, Hashimoto D, Igarashi T, Takahashi M, Kumaoka H et al.. An inferior mesenteric-caval shunt via the internal iliac vein with portosystemic encephalopathy. Internal medicine (Tokyo, Japan) 2001. link
2 Watanabe A. Portal-systemic encephalopathy in non-cirrhotic patients: classification of clinical types, diagnosis and treatment. Journal of gastroenterology and hepatology 2000. link